# Trial of Tirzepatide for the Treatment of Cannabis Use Disorder

> **NCT07468552** · PHASE2 · NOT_YET_RECRUITING · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 100 (estimated)

## Conditions studied

- Cannabis Use Disorder

## Interventions

- **DRUG:** Tirzepatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07468552
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-15
- **Primary completion:** 2028-03-15
- **Final completion:** 2028-11-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07468552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07468552, "Trial of Tirzepatide for the Treatment of Cannabis Use Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07468552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*